Atherton
Atherton is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Atherton.
Frequently Asked Questions
Who founded Atherton?
Atherton was founded by Bill Paseman (Co-founder, VP R&D).
Atherton is a company.
Key people at Atherton.
Atherton was founded by Bill Paseman (Co-founder, VP R&D).
Key people at Atherton.
Atherton was founded by Bill Paseman (Co-founder, VP R&D).
Atherton Venture Partners is a California-based venture capital and private equity firm that invests in healthcare, life sciences, and information technology companies.[1][2] Its mission centers on backing innovative companies in these sectors, with a current portfolio emphasizing high-growth opportunities in tech-driven healthcare and IT.[1] The firm's investment philosophy focuses on early- to growth-stage ventures, leveraging its private equity expertise to support scalable businesses, contributing to the startup ecosystem by providing capital and strategic guidance to transformative companies in critical industries.[2]
Founded in the late 20th century as a prominent Silicon Valley player (exact year not specified in available data), Atherton Venture Partners emerged during the tech boom, evolving from a focus on broad tech investments to a sharpened emphasis on healthcare, life sciences, and information technology.[1][2] Key partners have built a reputation through decades of deal-making in California's innovation hub, adapting to market shifts like the rise of biotech and digital health, with pivotal moments including high-profile exits that solidified its track record.[2]
Atherton Venture Partners rides the convergence of AI-driven healthcare, biotech breakthroughs, and enterprise IT modernization, trends accelerated by post-pandemic digital transformation and aging populations demanding innovative solutions.[1] Timing is ideal amid surging investments in life sciences (projected to grow amid regulatory tailwinds) and IT resilience plays, with market forces like talent concentration in California favoring its location.[2] The firm influences the ecosystem by funding companies that bridge tech and medicine, fostering startups that address global challenges like personalized medicine and data-secure health tech.
Atherton is poised to capitalize on AI-healthcare integration and sustainable biotech, with trends like precision medicine and cybersecurity in IT shaping its next investments. Expect expanded focus on Series B/C rounds as portfolio companies scale amid economic recovery. Its influence will evolve by mentoring the next wave of unicorns, reinforcing its role as a steady force in venture—much like its foundational bet on California's enduring innovation engine.[1][2]